• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Cerveau Technologies

Cerveau inks licensing deal with AbbVie for tau imaging agent

October 23, 2017 By Sarah Faulkner

Cerveau

Cerveau Technologies has inked a deal to license and supply AbbVie (NYSE:ABBV) with its [F-18]MK-6240 investigational tau imaging agent, the company said today. After the FDA cleared the investigational new drug application for Cerveau’s imaging agent in June, the company said it planned to work with pharmaceutical partners to evaluate the product’s use in positron emission tomography scans […]

Filed Under: Clinical Trials, Featured, Imaging, Neurological, Pharmaceuticals, Wall Street Beat Tagged With: AbbVie, Cerveau Technologies

FDA clears IND for Cerveau’s tau imaging agent

June 16, 2017 By Sarah Faulkner

Cerveau

Cerveau Technologies said today that the FDA cleared the investigational new drug application for its tau imaging agent. The company plans to work with pharmaceutical partners to evaluate the product’s use in positron emission tomography scans to assess neurofibrillary tangles in the brain. NFTs composed of aggregated tau protein are characteristic of certain neurodegenerative conditions like […]

Filed Under: Clinical Trials, Diagnostics, Featured, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance Tagged With: Cerveau Technologies, Merck

Cerveau Technologies, Wisconsin Alzheimer’s Center ink research deal

March 6, 2017 By Sarah Faulkner

Cerveau

Cerveau Technologies said today that it landed a clinical research agreement with the University of Wisconsin-Madison Alzheimer’s Research Center to study an early stage imaging agent with positron emission tomography scans to assess the status and progression of neurofibrillary tangles in the brain. Neurofibrillary tangles composed of tau protein are characteristic of certain neurodegenerative diseases, […]

Filed Under: Diagnostics, Featured, Imaging, Neurological, Research & Development Tagged With: Cerveau Technologies

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS